Bandaram Pharma Packtech Ltd

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 August 2026, providing investors with an up-to-date view of the company’s performance and outlook.

For the third consecutive session, Bandaram Pharma Packtech Ltd has declined, culminating in a fresh 52-week low of Rs 17.25 on 20 Aug 2026. This marks a near 65% drop from its 52-week high of Rs 49.7, underscoring sustained selling pressure despite pockets of financial improvement.

A sharp decline of over 65% from its 52-week high has dragged Bandaram Pharma Packtech Ltd to a fresh 52-week low of Rs 17.45 on 13 Aug 2026, marking a significant underperformance against the broader market and its sector peers.

For the fifth consecutive session, Bandaram Pharma Packtech Ltd closed lower, slipping to a fresh 52-week low of Rs 18 on 12 Aug 2026, marking a steep 63.7% decline from its 52-week high of Rs 49.7. This persistent downtrend contrasts sharply with the broader market, where the Sensex trades just 3.15% lower over the past year.

For the second consecutive session, Bandaram Pharma Packtech Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 18.52 on 11 Aug 2026. This drop comes amid a broader sector rally, highlighting a stark divergence in performance.

Bandaram Pharma Packtech Ltd’s stock price declined to a fresh 52-week low of Rs.19.11 on 6 August 2026, marking a significant downturn amid a series of consecutive losses. The stock has underperformed its sector and broader market indices, reflecting ongoing concerns about its financial health and market positioning.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 06 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

For the fourth consecutive session, Bandaram Pharma Packtech Ltd has declined, culminating in a fresh 52-week low of Rs 19.5 on 5 Aug 2026. This marks a significant 60.7% drop from its 52-week high of Rs 49.7, underscoring persistent selling pressure despite some pockets of financial improvement.

For the third consecutive session, Bandaram Pharma Packtech Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 19.51 on 4 Aug 2026. This marks a steep 48.68% drop over the past year, significantly underperforming the Sensex's modest 3.20% decline during the same period.

A sharp decline has dragged Bandaram Pharma Packtech Ltd to a fresh 52-week low of Rs 19.8 on 3 Aug 2026, marking a 44.12% drop over the past year and signalling sustained pressure on this healthcare services micro-cap despite broader market gains.

For the second consecutive session, Bandaram Pharma Packtech Ltd has seen its share price decline sharply, hitting a fresh 52-week low of Rs 19.99 on 28 Jul 2026. This latest drop extends the stock’s year-long slide, which now stands at a steep 47.37% loss, significantly underperforming the broader Sensex’s modest 4.89% decline over the same period.

A sharp decline of 14.89% intraday dragged Bandaram Pharma Packtech Ltd to a fresh 52-week low of Rs 20 on 27 Jul 2026, marking a significant 44.5% drop over the past year. This comes despite the broader market's positive momentum, with the Sensex trading 0.84% higher, highlighting a stark divergence in performance.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.

Bandaram Pharma Packtech Ltd’s stock price has declined to a fresh 52-week low of ₹22 on 03 Jul 2026, marking a significant milestone in its ongoing downward trajectory. The stock closed just 4.35% above this low, reflecting persistent pressure amid broader sector and market dynamics.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 June 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 June 2026, providing investors with an up-to-date view of the company’s performance and outlook.